Phosphodiesterase Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
VRNA | A | Verona Pharma plc | -0.62 | |
ITCI | B | Intra-Cellular Therapies Inc. | -0.61 | |
VTVT | C | vTv Therapeutics Inc. | -0.32 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PSIL | C | AdvisorShares Psychedelics ETF | 4.94 | |
IBRN | C | iShares Neuroscience and Healthcare ETF | 4.16 | |
XPH | B | SPDR S&P Pharmaceuticals ETF | 4.01 | |
FBT | D | First Trust Amex Biotech Index Fund | 3.9 | |
IHE | D | iShares U.S. Pharmaceutical ETF | 3.33 |
Compare ETFs
- Phosphodiesterase
A phosphodiesterase (PDE) is an enzyme that breaks a phosphodiester bond. Usually, phosphodiesterase refers to cyclic nucleotide phosphodiesterases, which have great clinical significance and are described below. However, there are many other families of phosphodiesterases, including phospholipases C and D, autotaxin, sphingomyelin phosphodiesterase, DNases, RNases, and restriction endonucleases (which all break the phosphodiester backbone of DNA or RNA), as well as numerous less-well-characterized small-molecule phosphodiesterases.
The cyclic nucleotide phosphodiesterases comprise a group of enzymes that degrade the phosphodiester bond in the second messenger molecules cAMP and cGMP. They regulate the localization, duration, and amplitude of cyclic nucleotide signaling within subcellular domains. PDEs are therefore important regulators of signal transduction mediated by these second messenger molecules.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles